APA

Morawska K., Goirand F., Marceau L., Devaux M., Cueff A., Bertaut A., Vincent J., Bengrine-Lefevre L., Ghiringhelli F. & Schmitt A. (2018). 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer. : Oncotarget.

Chicago

Morawska Katarzyna, Goirand Françoise, Marceau Laurine, Devaux Madeline, Cueff Adèle, Bertaut Aurélie, Vincent Julie, Bengrine-Lefevre Leila, Ghiringhelli François and Schmitt Antonin. 2018. 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer. : Oncotarget.

Harvard

Morawska K., Goirand F., Marceau L., Devaux M., Cueff A., Bertaut A., Vincent J., Bengrine-Lefevre L., Ghiringhelli F. and Schmitt A. (2018). 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer. : Oncotarget.

MLA

Morawska Katarzyna, Goirand Françoise, Marceau Laurine, Devaux Madeline, Cueff Adèle, Bertaut Aurélie, Vincent Julie, Bengrine-Lefevre Leila, Ghiringhelli François and Schmitt Antonin. 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer. : Oncotarget. 2018.